{"id":4568,"date":"2024-08-07T09:45:50","date_gmt":"2024-08-07T09:45:50","guid":{"rendered":"https:\/\/arauphar.com\/site\/?post_type=product&#038;p=4568"},"modified":"2024-08-07T09:51:28","modified_gmt":"2024-08-07T09:51:28","slug":"oxarin-40mg-0-4ml-injection","status":"publish","type":"product","link":"https:\/\/arauphar.com\/site\/product\/oxarin-40mg-0-4ml-injection\/","title":{"rendered":"Oxarin 40mg\/0.4ml injection"},"content":{"rendered":"<body><ul>\n<li>For the prevention and treatment of deep vein thrombosis (DVT) and prevent pulmonary embolism.\u00a0<\/li>\n<li>A trusted anticoagulant<\/li>\n<\/ul>\n<h4>Indications<\/h4>\n<ol>\n<li>Oxarin is indicated for the prophylaxis of deep vein thrombosis (DVT) which can lead to pulmonary embolism:<br>\n\u2022 To prevent the formation of deep vein thrombosis (blood clots), which can occur as a complication during orthopedic surgery such as hip or knee surgery or an intra-abdominal procedure (in the body cavity beneath the diaphragm containing the stomach, intestines, liver and other organs);<br>\n\u2022 Prevent the formation of deep vein thrombosis in hospitalized patients at risk of thromboembolic complications (obstruction of a blood vessel by a blood clot) due to severely restricted mobility during acute illnesses (heart failure [reduced capacity of the heart to pump blood], respiratory) failure or serious chest infections);<br>\n\u2022 Treat deep vein thrombosis with or without pulmonary embolism (blockage of blood vessels in the lungs).<\/li>\n<li>Prophylaxis of ischemic complications of unstable angina and non-Q wave myocardial infarction<br>\nOXARIN is indicated for the prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction, when administered concomitantly with aspirin.<\/li>\n<li>Treatment of acute ST-segment elevation myocardial infarction<br>\nAdministered concurrently with aspirin, OXARIN has been shown to reduce the combined effect rate of recurrent myocardial infarction or death in patients with acute ST-segment elevation myocardial infarction (STEMI). ).<\/li>\n<li>Prevention of thrombus formation during hemodialysis<br>\n\u2022 Deep vein thrombosis prophylaxis, abdominal surgery<br>\n\u2022 Deep vein thrombosis prophylaxis, knee arthroplasty<br>\n\u2022 Deep vein thrombosis prophylaxis, hip arthroplasty<br>\n\u2022 Prophylaxis of deep vein thrombosis in medical patients<br>\n\u2022 Acute deep vein thrombosis without pulmonary embolism, hospital treatment<br>\n\u2022 Unstable angina and non-Q wave myocardial infarction<br>\n\u2022 Acute myocardial infarction with ST segment elevation in patients younger than 75 years<br>\n\u2022 Acute myocardial infarction with ST segment elevation in patients aged \u2265 75 years<\/li>\n<li>Reduce the dose in patients with severe renal impairment<br>\n\u2022 Prophylaxis in abdominal surgery<br>\n\u2022 Prophylaxis in hip replacement or knee surgery<br>\n\u2022 Prophylaxis in hospitalized patients with an acute illness<br>\n\u2022 Hospital treatment of acute deep vein thrombosis with or without pulmonary embolism, when administered in combination with warfarin sodium.<br>\n\u2022 Pulmonary embolism treatment<br>\n\u2022 Outpatient treatment of acute deep vein thrombosis without pulmonary embolism, when administered in combination with warfarin sodium<br>\n\u2022 Prophylaxis of ischemic complications of unstable angina and non-Q wave myocardial infarction, when administered simultaneously with aspirin<br>\n\u2022 Treatment of acute myocardial infarction with ST-segment elevation in patients aged less than 75 years, in combination with aspirin<br>\n\u2022 Treatment of acute ST-segment elevation myocardial infarction in patients over 75 years of age in combination with aspirin<br>\n\u2022 Prevention of coagulation in the extracorporeal circuit during hemodialysis<\/li>\n<\/ol>\n<\/body>","protected":false},"excerpt":{"rendered":"<h4>Composition<\/h4>\n<p>Each 0.4ml contains: Enoxaparin sodium 40mg<\/p>\n","protected":false},"featured_media":4570,"template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"product_brand":[],"product_cat":[140,104],"product_tag":[],"class_list":{"0":"post-4568","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anticoagulant-anti-hemorrhagic","7":"product_cat-pharmaceuticals","9":"first","10":"instock","11":"shipping-taxable","12":"product-type-external"},"aioseo_notices":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/arauphar.com\/site\/wp-json\/wp\/v2\/product\/4568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arauphar.com\/site\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/arauphar.com\/site\/wp-json\/wp\/v2\/types\/product"}],"version-history":[{"count":2,"href":"https:\/\/arauphar.com\/site\/wp-json\/wp\/v2\/product\/4568\/revisions"}],"predecessor-version":[{"id":4574,"href":"https:\/\/arauphar.com\/site\/wp-json\/wp\/v2\/product\/4568\/revisions\/4574"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/arauphar.com\/site\/wp-json\/wp\/v2\/media\/4570"}],"wp:attachment":[{"href":"https:\/\/arauphar.com\/site\/wp-json\/wp\/v2\/media?parent=4568"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/arauphar.com\/site\/wp-json\/wp\/v2\/product_brand?post=4568"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/arauphar.com\/site\/wp-json\/wp\/v2\/product_cat?post=4568"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/arauphar.com\/site\/wp-json\/wp\/v2\/product_tag?post=4568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}